Gentium S.p.A. announced today that the European Commission has granted a Marketing Authorization for DefitelioA for the treatment of severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy.
http://www.biospace.com/news_story.aspx?StoryID=312550&full=1
http://www.biospace.com/news_story.aspx?StoryID=312550&full=1
No comments:
Post a Comment